Zaburzenia czynności kanałów jonowych w patogenezie padaczek idiopatycznych

Baraister, 1990, The genetics of neurological disorders Zieliński, 1974 Hauser, 1992, Seizure disorders: the changes with age, Epilepsia, 33, 6, 10.1111/j.1528-1157.1992.tb06222.x Connor, 2000 Commission on Classification and Terminology of the International League Against Epilepsy, 1989, Proposal for revised classification of epilepsies and epileptic syndromes, Epilepsia, 30, 389, 10.1111/j.1528-1157.1989.tb05316.x Gourfinkel-An, 2004, Monogenic idiopathic epilepsies, Lancet Neurol, 3, 209, 10.1016/S1474-4422(04)00706-9 Guerrini, 2003, The genetic and molecular basis of epilepsy, Trends Mol Med, 9, 300, 10.1016/S1471-4914(03)00116-3 Zawilska, 2004, Receptory – uwagi wstępne, klasyfikacja Nicholls, 2001 Auerbach, 1998, Desensitization of mouse nicotinic acetylcholine receptor channels. A two-gate mechanism, J General Physiol, 112, 181, 10.1085/jgp.112.2.181 Unwin, 1995, Acetylocholinę receptor channel imaged in the open state, Nature, 373, 37, 10.1038/373037a0 Kao, 1986, Acetylcholine receptor binding site contains a disulfide crosslink between adjacent half-cystinyl residues, J Biol Chem, 261, 8085, 10.1016/S0021-9258(19)83877-2 Skangiel-Kramska, 2004, Receptory cholinergiczne Role, 1996, Nicotinic receptors in the development and modulation of CNS synapses, Neuron, 16, 1077, 10.1016/S0896-6273(00)80134-8 Summers, 1995, Effects of local and repeated systemic administration of (-) nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine, and serotonin in rat cortex, Neurochem Res, 20, 753, 10.1007/BF01705545 Vernino, 1992, Calcium modulation and high calcium permeability of neuronal nicotinic acetylcholine receptors, Neuron, 8, 127, 10.1016/0896-6273(92)90114-S Couturier, 1990, A neuronal nicotinic acetylcholine receptor subunit (alpha 7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX, Neuron, 5, 847, 10.1016/0896-6273(90)90344-F Scheffer, 1994, Autosomal dominant frontal epilepsy misdiagnosed as sleep disorder, Lancet, 343, 515, 10.1016/S0140-6736(94)91463-X Picard, 1999, Mutated nicotinic receptors responsible for autosomal dominant nocturnal frontal lobe epilepsy are more sensitive to carbamazepine, Epilepsia, 40, 1198, 10.1111/j.1528-1157.1999.tb00848.x Matsushima, 2002, Mutation (Ser284Leu) of neuronal nicotinic acetylcholine receptor a4 subunit associated with frontal lobe epilepsy causes faster desensitization of the rat receptor expressed in oocytes, Epilepsy Res, 48, 181, 10.1016/S0920-1211(01)00336-9 Kuryatov, 1997, Mutation causing autosomal dominant nocturnal frontal lobe epilepsy alters Ca2+ permeability, conductance, and gating of human a4?2 nicotinic acetylcholine receptors, J Neurosci, 17, 9035, 10.1523/JNEUROSCI.17-23-09035.1997 Steinlein, 1995, A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy, Nat Genet, 11, 201, 10.1038/ng1095-201 Saenz, 1999, Autosomal dominant nocturnal frontal lobe epilepsy in a Spanish family with a Ser252Phe mutation in the CHRNA4 gene, Arch Neurol, 56, 1004, 10.1001/archneur.56.8.1004 Steinlein, 2000, Independent occurrence of the CHRNA4 Ser248Phe mutation in Norwegian family with nocturnal frontal lobe epilepsy, Epilepsia, 41, 529, 10.1111/j.1528-1157.2000.tb00205.x McLellan, 2003, Phenotypic comparison of two Scottish families with mutations in different genes causing autosomal dominant nocturnal frontal lobe epilepsy, Epilepsia, 44, 613, 10.1046/j.1528-1157.2003.20102.x Hirose, 1999, A novel mutation of CHRNA4 responsible for autosomal dominant nocturnal frontal lobe epilepsy, Neurology, 53, 1749, 10.1212/WNL.53.8.1749 Phillips, 2000, A de novo mutation in sporadic nocturnal frontal lobe epilepsy, Ann Neurol, 48, 264, 10.1002/1531-8249(200008)48:2<264::AID-ANA20>3.0.CO;2-B Won Cho, 2002, Autosomal dominant nocturnal partial epilepsy (ADNPE) in a Korean kindred, Epilepsia, 42, 21 Różycka, 2003, Evidence for S284L mutation of the CHRNA4 in a white family with autosomal dominant nocturnal frontal lobe epilepsy, Epilepsia, 44, 1113, 10.1046/j.1528-1157.2003.07603.x Chen, 2009, A novel mutation of the nicotinic acetylcholine receptor gene CHRNA4 in sporadic nocturnal frontal lobe epilepsy, Epilepsy Res, 83, 152, 10.1016/j.eplepsyres.2008.10.009 Bertrand, 2005, The CHRNB2 mutation I312M is associated with epilepsy and distinct memory deficits, Neurobiol Dis, 20, 799, 10.1016/j.nbd.2005.05.013 Rodrigues-Pinguet, 2003, Five ADNFLE mutations reduce the CA2+ dependence of the mammalian a4b2 acetylcholine response, J Physiol, 550, 11, 10.1113/jphysiol.2003.036681 Rodrigues-Pinguet, 2005, Mutations linked to autosomal dominant nocturnal frontal lobe epilepsy affect allosteric Ca2+ activation of the {alpha}4{beta}2 nicotinic acetylcholine receptor, Mol Pharmacol, 68, 487, 10.1124/mol.105.011155 Galzi, 1996, Identification of calcium binding sites that regulate potentiation of a neuronal nicotinic acetylcholine receptor, EMBO J, 15, 5824, 10.1002/j.1460-2075.1996.tb00969.x von Krosigk, 1993, Cellular mechanisms of a synchronized oscillation in the thalamus, Science, 261, 361, 10.1126/science.8392750 Guipponi, 1997, A fok I polymorphism in the human neuronal nicotinic acetylcholine receptor alpha 4 subunit gene, Clin Genet, 51, 78, 10.1111/j.1399-0004.1997.tb02423.x Steinlein, 1997, Possible association of a silent polymorphism in the neuronal nicotinic acetylcholine receptor subunit α4 with common idiopathic generalizes epilepsies, Am J Med Genet, 74, 445, 10.1002/(SICI)1096-8628(19970725)74:4<445::AID-AJMG18>3.0.CO;2-I Dorszewska, 2005, Polymorphisms of the CHRNA4 gene encoding the alpha4 subunit of nicotinic acetylcholine receptor as related to the oxidative DNA damage and the level of apoptotic proteins in lymphocytes of the patients with Alzheimer's disease, DNA Cell Biol, 24, 786, 10.1089/dna.2005.24.786 Różycka, 2009, The 1674 +11C>T polymorphism of CHRNA4 is associated with juvenile myoclonic epilepsy, Seizure, 18, 601, 10.1016/j.seizure.2009.06.007 Haug, 2003, Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies, Nat Genet, 33, 527, 10.1038/ng1121 Suzuki, 2004, Mutations in EFHC1 cause juvenile myoclonic epilepsy, Nat Genet, 36, 842, 10.1038/ng1393 Chen, 2003, Association between genetic variation of CACNA1H and childhood absence epilepsy, Ann Neurol, 54, 239, 10.1002/ana.10607 Taske, 2002, Evaluation of the positional candidate gene CHRNA7 at the juvenile myoclonic epilepsy locus (EJM2) on chromosome 15q13-14, Epilepsy Res, 49, 157, 10.1016/S0920-1211(02)00027-X Escayg, 2000, Coding and non-coding variation of the human calcium-channel ß4-subunit gene CACNB4 in patients with idiopathic generalized epilepsy and episodic ataxia, Am J Hum Genet, 66, 1531, 10.1086/302909 Neubauer, 1998, Centrotemporal spikes in families with rolandic epilepsy: linkage to chromosome 15q14, Neurology, 51, 1608, 10.1212/WNL.51.6.1608 Cossette, 2002, Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy, Nat Genet, 31, 184, 10.1038/ng885 Krampfl, 2005, Molecular analysis of the A322D mutation in the GABAA receptor α1 – subunit causing juvenile myoclonic epilepsy, Eur J Neurosci, 22, 10, 10.1111/j.1460-9568.2005.04168.x Mehta, 1999, An update on GABAA receptors, Brain Res Rev, 29, 196, 10.1016/S0165-0173(98)00052-6 Czapiński, 2005, Mechanism of action of antiepileptic drugs, Curr Top Med Chem, 5, 3, 10.2174/1568026053386962 Bialer, 2002, Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI), Epilepsy Res, 51, 31, 10.1016/S0920-1211(02)00106-7 Lasoń, 2004, Receptorowe mechanizmy działania leków przeciw-padaczkowych, 11 Wallace, 2001, Mutant GABAA receptor γ2-subunit in childhood absence epilepsy and febrile seizures, Nat Genet, 28, 49, 10.1038/ng0501-49 Bowser, 2002, Altered kinetics and benzodiazepine sensitivity of a GABAA receptor subunit mutation [gamma 2(R43Q)] found in human epilepsy, Proc Natl Acad Sci USA, 99, 15170, 10.1073/pnas.212320199 Sieghart, 2002, Subunit composition, distribution and function of GABA(A) receptor subtypes, Curr Top Med Chem, 2, 795, 10.2174/1568026023393507 Sik, 2000, Distribution of chloride channel-2-immunoreactive neuronal and astrocytic processes in the hippocampus, Neuroscience, 101, 51, 10.1016/S0306-4522(00)00360-2 Baulac, 2001, First genetic evidence of GABAA receptor dysfunction in epilepsy: a mutation in the gamma2 subunit gene, Nat Genet, 28, 46, 10.1038/ng0501-46 Marini, 2003, Childhood absence epilepsy and febrile seizures: a family with a GABA(A) receptor mutation, Brain, 126, 230, 10.1093/brain/awg018 Janz, 1992, Do idiopathic generalized epilepsies share a common susceptibility gene?, Neurology, 42, 48 Bate, 1999, Molecular genetics of human epilepsies, Expert Rev Mol Med, 10, 1, 10.1017/S1462399499001349 Cooper, 2003, M-channels: neurological diseases, neuromodulation, and drug development, Arch Neurol, 60, 496, 10.1001/archneur.60.4.496 Wang, 1998, KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel, Science, 282, 1890, 10.1126/science.282.5395.1890 Schwake, 2000, Surface expression and single channel properties of KCNQ2/KCNQ3. M-type K+ channels involved in epilepsy, J Biol Chem, 275, 13343, 10.1074/jbc.275.18.13343 Singh, 1998, A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns, Nat Genet, 18, 25, 10.1038/ng0198-25 Dedek, 2003, Neonatal convulsions and epileptic encephalopathy in an Italian family with a missense mutation in the fifth transmembrane region of KCNQ2, Epilepsy Res, 54, 21, 10.1016/S0920-1211(03)00037-8 Hirose, 2000, A novel mutation of KCNQ3 (c.925T?C) in a Japanese family with benign familial neonatal convulsions, Ann Neurol, 47, 822, 10.1002/1531-8249(200006)47:6<822::AID-ANA19>3.0.CO;2-X Claes, 2004, De novo KCNQ2 mutations in patients with benign neonatal seizures, Neurology, 63, 2155, 10.1212/01.WNL.0000145629.94338.89 Richards, 2004, Novel mutations in the KCNQ2 gene link epilepsy to a dysfunction of the KCNQ2-calmodulin interaction, J Med Genet, 41, 35, 10.1136/jmg.2003.013938 Catterall, 2000, Structure and regulation of voltage-gated Ca2 + channels, Ann Rev Cell Dev Biol, 16, 521, 10.1146/annurev.cellbio.16.1.521 Imbrici, 2004, Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia, Brain, 127, 2682, 10.1093/brain/awh301 Jouvenceau, 2001, Human epilepsy associated with dysfunction of the brain P/Q-type calcium channel, Lancet, 358, 801, 10.1016/S0140-6736(01)05971-2 Steinlein, 2002, Channelopathies can cause epilepsy in man, Eur J Pain, 6, 27, 10.1053/eujp.2001.0319 Perucca, 2005, An introduction to antiepileptic drugs, Epilepsia, 46, 31, 10.1111/j.1528-1167.2005.463007.x Goldin, 2003, Mechanisms of sodium channel inactivation, Curr Opin Neurobiol, 3, 284, 10.1016/S0959-4388(03)00065-5 Heron, 2002, Sodium-channel defects in benign familial neonatal infantile seizures, Lancet, 360, 851, 10.1016/S0140-6736(02)09968-3 Sugawara, 2001, A missense mutation of the Na+ channel alpha II subunit gene Na(v)1.2 in a patient with febrile and afebrile seizures causes channel dysfunction, Proc Natl Acad Sci USA, 98, 6384, 10.1073/pnas.111065098 Wallace, 2002, Generalized epilepsy with febrile seizures plus: mutation of the sodium channel subunit SCN1B, Neurology, 58, 1426, 10.1212/WNL.58.9.1426 Audenaert, 2003, A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy, Neurology, 61, 854, 10.1212/01.WNL.0000080362.55784.1C Wallace, 1998, Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B, Nat Genet, 19, 366, 10.1038/448 Scheffer, 2007, Temporal lobe epilepsy and GEFS+ phenotypes associated with SCN1B mutations, Brain, 130, 100, 10.1093/brain/awl272 Wallace, 2001, Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus, Am J Hum Genet, 68, 859, 10.1086/319516 Ito, 2002, Autosomal dominant epilepsy with febrile seizures plus with missense mutations of the sodium-channel alpha 1 subunit gene, SCN1A, Epilepsy Res, 48, 15, 10.1016/S0920-1211(01)00313-8 Annesi, 2003, Two novel SCN1A missense mutations in generalized epilepsy with febrile seizures plus, Epilepsia, 44, 1257, 10.1046/j.1528-1157.2003.22503.x Mulley, 2005, SCN1A mutations and epilepsy, Hum Mutat, 25, 535, 10.1002/humu.20178 Claes, 2001, De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy, Am J Hum Genet, 68, 1327, 10.1086/320609 Nabbout, 2003, Spectrum of SCN1α mutations in severe myoclonic epilepsy of infancy, Neurology, 60, 1961, 10.1212/01.WNL.0000069463.41870.2F Rhodes, 2004, Non-inactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy, Proc Natl Acad Sci USA, 101, 11147, 10.1073/pnas.0402482101 Spampanato, 2003, Generalized epilepsy with febrile seizures plus type 2 mutation W1204R alters voltage-dependent gating of Nav1.1 sodium channels, Neuro-saence, 116, 37 Cossette, 2003, Functional characterization of the D188V mutation in neuronal voltage-gated sodium channel causing generalized epilepsy with febrile seizures plus (GEFS), Epilepsy Res, 53, 107, 10.1016/S0920-1211(02)00259-0 Spampanato, 2001, Functional effects of two voltage-gated sodium channel mutations that cause generalized epilepsy with febrile seizures plus type 2, J Neurosci, 21, 7481, 10.1523/JNEUROSCI.21-19-07481.2001 Li, 2010, Novel mutation of SCN1A in familial generalized epilepsy with febrile seizures plus, Neurosci Lett, 480, 211, 10.1016/j.neulet.2010.06.040 Picard, 2006, Alteration of the in vivo nicotinic receptor density in ADNFLE patients: a PET study, Brain, 129, 2047, 10.1093/brain/awl156